Autologous Human C-Kit Cardiac Stem Cells (CSCs) II (ISCI / University of Miami Miller School of Medicine)

N/A

Report date: 2023/01/01 08:30:57

Base Information

Drug NameAutologous Human C-Kit Cardiac Stem Cells (CSCs) II (ISCI / University of Miami Miller School of Medicine)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy > Cardiac stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsStem cell growth factor receptor
Therapy Area/IndicationsVentricular Dysfunction, LeftMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesElpiscience (Shanghai) Biopharma LtdUniversity Of Miami
China Registration ClassN/A

Develop Information

Active CompaniesElpiscience (Shanghai) Biopharma LtdUniversity Of Miami
Inactive CompaniesN/A
Active IndicationsVentricular Dysfunction, LeftMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A